WELCOME to HIV-NAT!
The HIV Netherlands Australia Thailand Research Collaboration. HIVNAT is affiliated with The Thai Red Cross AIDS Research Centre in Bangkok, Thailand, with the Kirby Institute for infection and immunity in society in Sydney, Australia, and with the Amsterdam Institute for Global Health and Development in Amsterdam, The Netherlands. Since 1996 our centre has been conducting clinical research in HIV, meeting international standards, and gaining vast experience in the coordination of multicentre trials in Thailand.
Follow us on:
May 15, 2012
We are pleased to announce that the program for the 16th Bangkok International Symposium on HIV Medicine which will take place at the Queen Sirikit Na ... Read More
May 11, 2012
A summary of the 15th Bangkok International Symposium on HIV Medicine (January 2012, Bangkok, Thailand), written by Dr. Amanda Clarke and other HIV-NA ... Read More
April 19, 2012
As we are busy preparing for the 2013 Bangkok International Symposium, it gives me a great pleasure to recap some hot topics from the last Symposium. ... Read More
March 27, 2012
Her Royal Highness Princess Soamsawali graciously presided over the opening ceremony of 'You are not alone: for the same world we share' exhibition at ... Read More
March 27, 2012
Once again, we at HIV-NAT are delighted to welcome physicians from 9 countries in Asia. Up to 43 physicians will be trained in HIV and hepatic disease ... Read More
HIV-NAT Conferences & Trainings
One of the best HIV medicine conferences in Asia Pacific, the Bangkok International Symposium brings together experts in the HIV field from all over the world. The next Symposium will take place from 16-18 January 2013.
Scheduled to take place twice a year, the Symposium Series training workshops are centered on care management and treatment for people living with HIV/AIDS. The purpose of the training workshop is to provide in-depth knowledge on HIV care and treatment to medical doctors, nurses, pharmacists and healthcare practitioners. The training workshops are conducted in Thai.
One of the leading causes of death among people living with HIV, tuberculosis remains a serious threat for HIV-infected people. Antiretroviral drugs ... Read More
- Immunologic and virologic failure after first-line highly active antiretroviral therapy in HIV-infected children.
- Neither branded nor generic lopinavir/ritonavir produces adequate lopinavir concentrations at a reduced dose of 200/50 mg BID.
- Factors associated with elevated ALT in an international HIV/HBV co-infected cohort on long-term HAART.
Mar 26-28, 2012
Feb 13-15, 2012
Feb 27-28, 2012
Jan 30, 2012
© Copyright 2012 HIV-NAT. All Rights Reserved.
The HIV Netherlands Australia Thailand Research Collaboration